Magnesiocard

Magnesium L-Aspartate Hydrochloride Trihydrate, the active ingredient in Magnesiocard, is a magnesium supplement presented as a tablet for oral use. It supports magnesium repletion in individuals with low magnesium levels or increased physiological demand and may aid in normal neuromuscular function and electrolyte balance.

GNH USA supplies Magnesiocard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for cross‑border distribution. Customers benefit from reliable supply chains and responsive technical support.

Magnesiocard is used to address conditions related to magnesium deficiency and its physiological effects. - Magnesium deficiency: helps restore normal serum magnesium concentrations. - Hypomagnesemia: supports correction of low magnesium levels in clinical settings. - Muscle cramps: may reduce frequency and intensity of cramps associated with low magnesium. - Premenstrual syndrome: may alleviate symptoms linked to magnesium depletion. - Migraine prophylaxis: may be used as adjunct in individuals with magnesium‑related triggers. - Cardiac arrhythmias: may assist in stabilizing cardiac rhythm in magnesium‑deficient patients.

Magnesiocard may be associated with a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Diarrhea: loose stools occurring after ingestion. - Abdominal discomfort: mild stomach pain or cramping. - Nausea: feeling of sickness. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Hypermagnesemia: elevated serum magnesium causing muscle weakness or cardiac effects. - Arrhythmia: irregular heart rhythm in susceptible individuals. - Hypotension: significant drop in blood pressure. - Allergic reaction: rash, itching, or swelling. - Respiratory depression: rare severe suppression of breathing.

When using Magnesiocard, certain precautions should be observed to ensure safe and effective therapy. - Renal function assessment: evaluate kidney performance before initiating therapy. - Serum magnesium monitoring: check levels periodically during treatment. - Cardiac condition caution: use carefully in patients with heart block or arrhythmias. - Hypermagnesemia avoidance: discontinue if serum magnesium exceeds normal range. - Pregnancy and lactation: safety not established; weigh benefits against potential risks. - Store at ambient temperature: keep below 25 °C in original packaging, protect from moisture.

Magnesiocard can interact with several medicines, altering their absorption or effects.

Major Interactions (Avoid): - Aminoglycoside antibiotics: reduced efficacy due to chelation. - Bisphosphonates: impaired absorption when taken together. - Tetracycline antibiotics: decreased absorption from chelation. - Loop diuretics: may increase risk of hypermagnesemia. - Calcium channel blockers: additive effects on cardiac conduction.

Moderate Interactions (Monitor Closely): - Oral iron supplements: reduced magnesium absorption. - Proton pump inhibitors: may affect magnesium levels. - Oral contraceptives: potential alteration of magnesium balance. - Statins: monitor for muscle‑related side effects. - NSAIDs: increased risk of renal impairment.